As Purdue Pharma grapples with thousands of lawsuits blaming the company for contributing to the opioid crisis, the drug maker has signaled it may file bankruptcy. If that happens, some newly created subsidiaries are likely to come under scrutiny.

Over the past several months, Purdue has launched two limited partnerships that are now marketing or developing drugs that were previously listed as part of the Purdue product portfolio. Several current and former Purdue executives run these companies, both of which the drug maker refers to as operating subsidiaries. And a Purdue entity holds trademark rights for their names.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

  • The article should state that there is not a relationship between Purdue Pharma and Purdue University.

  • The Sacklers wholesaled opiates to Americans, with the help of the regulators. They lied about their product, and created a false narrative, which the media is still following to cover their tracks. So far the only people punished, where the DEA agents who tried to enforce the law. They will at least try to get away with hiding their assets, it is the American way. They have gotten away with all of it for this long.

  • Quite a turn of phrase – “In legal parlance, such concerns are known as fraudulent conveyance” – mr ed. Now what kind of noble and upstanding corporate entity would attempt such a thing? (Rhetorical question – or “April Fools?)

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy